Works matching IS 11732563 AND DT 2011 AND VI 31 AND IP 3
Results: 6
Effects of Manidipine and its Combination with an ACE Inhibitor on Insulin Sensitivity and Metabolic, Inflammatory and Prothrombotic Markers in Hypertensive Patients with Metabolic Syndrome.
- Published in:
- Clinical Drug Investigation, 2011, v. 31, n. 3, p. 201, doi. 10.2165/11587590-000000000-00000
- Publication type:
- Article
Importance of C-Reactive Protein Level in Predicting Non-Response to Additional Intravenous Immunoglobulin Treatment in Children with Kawasaki Disease.
- Published in:
- Clinical Drug Investigation, 2011, v. 31, n. 3, p. 191, doi. 10.2165/11538910-000000000-00000
- Publication type:
- Article
Effects of Structured Follow-Up and of More Effective Acid Inhibitory Treatment in the Management of GORD Patients in a Swedish Primary-Care Setting.
- Published in:
- Clinical Drug Investigation, 2011, v. 31, n. 3, p. 181, doi. 10.2165/11586330-000000000-00000
- Publication type:
- Article
Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics.
- Published in:
- Clinical Drug Investigation, 2011, v. 31, n. 3, p. 169, doi. 10.2165/11538700-000000000-00000
- Publication type:
- Article
Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers.
- Published in:
- Clinical Drug Investigation, 2011, v. 31, n. 3, p. 155, doi. 10.2165/11586630-000000000-00000
- Publication type:
- Article
Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone.
- Published in:
- Clinical Drug Investigation, 2011, v. 31, n. 3, p. 143, doi. 10.2165/11539950-000000000-00000
- Publication type:
- Article